fibrin. Live macrophages also degraded insoluble elastin only when in contact with the elastin but could do so even in the presence of serum proteinase inhibitors. In matrices containing a mixture of fibrin and elastin, cells did not degrade elastin unless plasminogen was added to the medium. These results indicate that normal alveolar macrophages synthesize and express, probably at the cell surface, a PA. The PA is physically and immunochemically similar to urokinase but is membrane bound. The PA is critical to the degradation of fibrin matrices by normal alveolar macrophages. Under tissue conditions where elastin is embedded within other structural proteins, the activator may be rate-limiting in elastin degradation as well. The findings also suggest that live macrophage proteolytic activity is relatively insensitive to the presence of serum proteinase inhibitors, suggesting a mechanism for proteolytic lung injury even in the presence of proteinase-proteinase inhibitor balance in the soluble phase.
b bstract. Fibrin deposition is prominent in the histopathology ofa number ofinflammatory lung diseases. Plasmin, activated locally in the lung, can degrade not only this fibrin but potentially structural proteins important to normal lung architecture. Because alveolar macrophages are prominent in inflammatory processes ofthe lung, we examined the plasminogen activator (PA) activity of human alveolar macrophages. Intact alveolar macrophages from each of 10 healthy subjects expressed PA activity. There was no difference in activity between smoking and nonsmoking individuals. The activator activity was largely cell-associated, but under certain culture conditions, macrophages released a soluble activator into the culture medium. The membrane-bound activator had an apparent molecular mass of 52-55 kD in nonreduced sodium dodecyl sulfate (SDS) gels, and monospecific antibody to urokinase neutralized the enzyme activity. Im- 
munoprecipitation of [35S]methionine-labeled cells
showed that human alveolar macrophages actually synthesize the PA in vitro. SDS-gel analysis of the immunoprecipitated material revealed the predominant species of PA to be structurally similar to reduced, active urokinase. We also examined the role of PA in the degradation of both insoluble fibrin and elastin matrices by live macrophages. Cells degraded an insoluble fibrin matrix in the presence of plasminogen whether or not the macrophages contacted the fibrin as long as proteinase inhibitors were not in the culture medium. In the presence of serum proteinase inhibitors, macrophages still degraded a fibrin matrix, but only if they were in contact with the Introduction Plasminogen activator (PA),I by limited proteolysis of its major macromolecular substrate, plasminogen, subserves a number of biological roles. Plasmin generation is clearly important in the resolution offibrin deposited in the vasculature (1) . In this case, the major sources of PA are precursors circulating in blood and endothelial cells (2) (3) (4) . Plasmin is also important to the degradation of fibrin deposited in tissues at inflammatory sites. A number, if not all, inflammatory cells elaborate PA (5-7). In addition, there is a strong correlation between the motility of such noninflammatory cells as oocytes and neurons and their expression ofPA activity (8, 9) . This association suggests plasmin may be important to the degradation of basement membrane and extracellular matrix proteins as well as fibrin. Vassalli et al. (10) have thus proposed PA via plasmin formation to be critical to the migration of cells through tissue barriers.
As might be expected, macrophages have the potential to express PA activity (1 1). In mice, the PA activity correlates with the activation state of the macrophages (12) . Recently, we observed that stimulated mouse peritoneal macrophages express both a membrane-bound, cell surface PA (PAm) as well as a soluble PA (PA,) (13) . The PAm activity is important to the fibrinolytic activity of the cell because PAm is relatively resistant to soluble proteinase inhibitors also secreted by macrophages. Plasmin once bound to fibrin has a threefold order of magnitude decrease in its sensitivity to the major blood antiplasmin, a-2-antiplasmin (14) . Thus, murine macrophages can degrade a fibrin matrix in the presence of proteinase inhibitors by focusing fibrinolysis at or near the cell surface. Whether human macrophages have a similar fibrinolytic mechanism is unknown.
In this study, we examined the fibrinolytic activity of human alveolar macrophages. We first examined the enzymatic pathways by which these cells degrade fibrin. We (16, 17) .
Reagents. Animal and human sera were prepared and stored as previously described (13) . Human plasminogen (plg) was obtained from Helena Laboratories (Beaumont, TX) and was determined to be free of detectable plasmin in a '25I-fibrin plate assay at concentrations used in the experiments. Urokinase, obtained from the American Red Cross (Washington, DC), was stored at -70'C. Urokinase was radiolabeled with carrier-free 1251 (New England Nuclear, Boston, MA, 17 Ci/mg) by a chloramine-T method (18 (21) . 48 X 106 total cells, >95% macrophages, lavaged from a smoking subject were mechanically homogenized in 0.25 M sucrose, 10 mM Tris, 1 mM EDTA, pH 7.4, a.td centrifuged at 1,500 g to remove nuclei and fragmented cells. A membrane fraction was then prepared by centrifugation at 100,000 g for 90 min at 4°C. The fraction contains microsomal, granule, and plasma membrane elements (22) . The preparation was repeated with cells from four additional smokers and in two of these subjects additional proteinase inhibitors (100 U/ml trasylol and 1 mM phenylmethanesulfonyl fluoride) were added to the homogenizing buffer. The membrane fraction was dissolved in 3% SDS, 10% glycerol, 0.0625 M Tris, pH 6.3, and the membrane equivalent of 12 x 106 cells electrophoresed in triplicate in 10% acrylamide SDS gels at room temperature.
A nonreducing Laemmli buffer system was used for electrophoresis (23) . The gels were soaked in 0.5% Triton X-100 in PBS (pH 7.4) for I h, then 2 h in H20, and then cut into 1-mm slices. The 1-mm gel slices were assayed for PA activity in '251-fibrin-coated microtiter wells. Because large amounts of plg were necessary in these experiments, we used 1% acid-treated dog serum in 200 Ml DME/well as a source of plg. No fibrin degradation occurred in the absence of supplemental pig. Companion gel slices, generally 6-8, from the region determined to contain PA were also examined for cross-reaction with antibody to urokinase as judged by neutralization of PA activity. In these experiments, PA was assayed in '251-fibrin-coated microtiter chambers containing 200 Ml PBS or PBS with various dilutions of urokinase antibody. Purified urokinase or streptokinase empirically adjusted to equivalent PA activity as that of the gel slices (0.1 U/well and 0.01 U/well, respectively) served as controls. Packaging). In the case of fibrin and elastin mixtures, the fibrin appeared by scanning electron microscopy to coat the elastin, and very little fibrin was observable in its typical protomeric structure in the presence of the elastin (24) . After drying, the matrices were washed with PBS, the fibrinogen converted to fibrin, and the intact alveolar macrophages adhered either on or offthe matrices by tilting the culture chambers during adherence. By alternating the halves of the culture well coated with fibrin and/or elastin, cells could be adhered both on and off the protein matrices in a single 24-well culture plate. After adherence, the cell monolayers were washed, the plates gently placed flat, and then incubated in 500 Mul of medium in standard fashion. By microscopy, at the end of each experiment, we confirmed that <0.1% of the total cells plated off the matrices migrated into the matrix during the culture period. Supernates were assayed for solubilized fibrin or elastin after 24-h incubation at 37°C as described above.
Metabolic labeling of macrophages, immunoprecipitation, and autoradiography. Adherent human alveolar macrophages were metabolically labeled at a density of 107 cells/25 cm2 in a tissue culture flask (Falcon Labware), 4 ml medium/flask. A total of -40 X 106 cells obtained from smoking subjects were labeled in each ofsix experiments. After adherence, the cells were incubated for 2 h at 370C in DME containing 10% fetal bovine serum. The cell monolayers were then washed and incubated for 18 h in 4 ml of medium consisting of DME containing 10% of the stock methionine (0.02 mM methionine), 0.5% fetal bovine serum, and 100 MCi/mI [35S]methionine (New England Nuclear, 1,000 Ci/mol sp act). After labeling, the cell monolayers were thoroughly washed in PBS, scraped, and pelleted by centrifugation. A membrane fraction of the macrophages containing all PA activity was prepared as described above and solubilized in PBS, pH 7.4, containing 0.1% SDS for subsequent immunoprecipitation. A urokinase antibody prepared in rabbits was obtained from Alpha Therapeutics Corp. (Los Angeles, CA) and used in immunoprecipitation experiments. The antibody contained IgG and some albumin contamination as defined by Coomassie Blue staining of electrophoresed antibody. Preliminary experiments indicated that the antibody would neutralize the PA activity of urokinase but not streptokinase in the fibrin plate assay. Also, the antibody immunoprecipitated 1251-urokinase in a specific fashion in that 2,500 U of unlabeled urokinase blocked the precipitation of 125I-urokinase. Immunoprecipitation with irrelevant antisera or the urokinase antibody was done in successive steps (25) . In the first step, solubilized cell membrane fractions or the '25I-urokinase, I00-Ml each, in PBS plus 0.1% SDS were mixed with 15 Ml antisera to antithrombin III (rabbit, Calbiochem-Behring Corp., San Diego, CA). After 2 h at room temperature, IgG was absorbed with 150 Ml of prewashed 10% Staphylococcus aureus (IgG Sorb, Enzyme Center, Inc., Boston, MA) and discarded after centrifugation at 10,000 g to recover the samples. This step was performed to eliminate any nonspecific binding of radiolabeled cell protein to S. aureus. 15 Ml of the urokinase antibody was then added to the samples and the precipitation step repeated with fresh, prewashed S. aureus. The precipitated complexes were removed from the S. aureus in sample buffer for SDS-gel electrophoresis by boiling for 2 min. The eluted proteins were then electrophoresed in 10% acrylamide slab gels under reducing conditions, dried, and autoradiographed for 14 d at -70°C using Kodak-Xomat-AR film (Eastman Kodak Co., Rochester, NY).
Protein determination. Protein concentration was determined by the method of Lowry (26) using a bovine albumin standard.
Results
Fibrinolytic activity of human alveolar macrophages. Intact alveolar macrophages from each of 10 community volunteers cultured on '25I-fibrin-coated plastic culture wells measurably degraded the fibrin within 4 h oftheir explanation (Fig. 1 ). That this fibrinolytic activity was PA-dependent is indicated by the clear difference in fibrinolytic activity (percent total fibrin degraded) when plg was added to the culture medium. The mean percent fibrin degraded for all subjects in the presence or absence of plg was 47 and 7%, respectively. The mean fibrinolytic activity of 105 human alveolar macrophages in the presence of plg corresponded to that of 0.8 U of urokinase under similar culture conditions. Seven of the subjects were nonsmokers, and three smoked an average of I pack/d. There was no difference in PA activity between the two groups. We questioned whether the PA activity expressed by intact macrophages represented PAs and/or cell-associated activity. Macrophages from these 10 subjects cultured overnight in serum-free DME or in DME supplemented with 1% dog or human serum did not release measurable PAS. However, when we cultured macrophages in acid-treated serum instead of whole serum or serum-free medium, the results were different. Macrophages obtained from an additional four of six subjects (four smokers, two nonsmokers) and incubated in 1% acid-treated, plg-free dog serum did release variable but measurable amounts of PA, (Table I) . By comparison with equivalent numbers of intact cells the PA, activity in 24-h conditioned medium was much less and corresponded to that of 0.06 U of urokinase/ I05 cells. We have previously studied the expression of PA by murine macrophages (13) . We observed that endotoxin, 10-100 ng/ml, added to macrophages in culture resulted in complete loss of PA, activity. Endotoxin did not block intact cell PA activity and instead actually increased membrane-bound PA. We tested the effect of endotoxin on PA release by human alveolar macrophages. As the data in Table I indicates, endotoxin 100 ng/ ml suppressed release of PA, by cultured human alveolar macrophages in the two subjects tested.
We considered the possibility that the low levels of PA, could represent contamination from PA released by human neutrophils. However, there was no difference in proportion of lavage cells that were neutrophils in secretors or nonsecretors, <2% in both groups. The conditions under which cells released the PA were limited, i.e., acid-treated serum, and the amount was small as a fraction of the total cellular PA activity under even optimal conditions. Whether acid-treated serum stimulated PA release or factors in whole serum suppressed activity is unclear. Serum factors have been shown to modulate cell-derived PA activity in other experimental systems (28, 29 Fig. 2 shows, only gel slices corresponding to 50-55 kD contained measurable PA activity. In five separate determinations from three smoking subjects, the peak PA activity migrated with an average, apparent molecular mass of 52 kD. The apparent molecular mass of PA was not influenced by the addition, in two subjects, of trasylol or phenylmethanesulfonyl fluoride to the cell lysing medium. Purified, nonreduced urokinase migrated with an apparent molecular mass of 53 kD (data not shown).
The data in Fig. 2 suggested macrophage PAm was urokinase-like. We therefore performed experiments to determine if Fig. 4 show two proteins synthesized by macrophages and precipitated by the urokinase antibody (A) that compare closely in size to the heavy and light chains of purified, reduced urokinase (B). In addition, a rather heavily labeled material appears at the interface of the 5% stacking and 10% separating gel (.250 kD) and three faint intermediate bands of 66, 60, and 50 kD were also apparent. We observed identical results with a PAm preparation from a second smoking subject (data not shown).
Degradation offibrin by intact human macrophages in the presence of soluble protease inhibitors. Intact normal alveolar macrophages lyse fibrin by a plg-dependent mechanism (Fig.  1) . These experiments were done in medium free of proteinase inhibitors and with cells in contact with the fibrin. We next examined the ability of intact macrophages to degrade fibrin in the presence of proteinase inhibitors. We coincubated cells and fibrin in tissue culture chambers where cells either were in contact with or remote to the fibrin. We then tested the effect of various sera on the extent of fibrinolysis by macrophages on or off the substrate. Since plasmin does not bind to macrophages (unpublished observations) in either case the plasmin is free to Urokinase Antibody (pug/ml) diffuse in the medium to the fibrin. The data in Table II show that macrophages incubated in tissue culture medium containing plg but depleted of proteinase inhibitors (by acid treatment) lysed the fibrin in an 18-h assay to an equivalent extent whether or not the cells were in contact with the fibrin. As before (Fig.  1) , cells incubated in pig-free medium had much less fibrinolytic activity, whether or not the cells were in contact. Cells cultured in medium rich in proteinase inhibitors, either fetal bovine serum or human serum, only hydrolyzed the fibrin when in contact with the substrate. The extent of lysis by cells on fibrin was 11 and 7 times that of cells off the fibrin for fetal bovine serum and human serum, respectively. Notably, cells incubated on the fibrin matrix hydrolyzed the fibrin to a similar extent in an 18-h assay whether or not proteinase inhibitors were in the medium. We should point out that the rate of degradation of fibrin was slower in either fetal serum or human serum than in serum-free medium, but fibrin was largely lysed in either case by 18 h. We report the findings at 18 h to illustrate how little degradation occurs in even 18 h if cells are cultured remote to the substrate in medium containing proteinase inhibitors.
Elastin degradation by intact human alveolar macrophages.
Human macrophages, especially those from smoking subjects, are known to contain elastase activity. At least part of this activity appears to be explained by neutrophil elastase on or within macrophages or by neutrophils contaminating the macrophage preparations (30) . However, recently reported studies indicate that human monocytes express a membrane-bound elastase and that human monocyte-derived macrophages contain an elastase that is not neutrophil elastase (31, 32) . Most assays of elastase activity utilize a detergent-treated elastin and, therefore, assay either lysed cells or conditioned medium from cultured cells (20, 30, 33, 34 elastin-only matrices in the presence ofplg (Table III) . The ratio of fibrin to elastin in the experiments reported in Table III was 40 Mg fibrin/l00 Mg elastin. We observed similar findings with 20 Mg fibrin to 100 Mg elastin but did not otherwise vary the ratio of fibrin to elastin. We next examined the role cell contact might have in elastin degradation by intact alveolar macrophages in identical experiments to those done with fibrin (Table II) . Cells were cultured for 24 h either in contact with or remote from a [3H]elastin substratum. The data in Table IV show that much greater elastinolysis occurred when cells were in contact with the matrix. The extent of elastinolysis by macrophages cultured on the substrate was 20-and 400-fold higher than that of cells cultured off elastin for assays done in fetal bovine serum and human serum, respectively. The data also indicate that when cells are incubated in contact with the substrate, the presence of serum proteinase inhibitors (1% fetal bovine serum or 1-10% human serum) had only a weak effect on the extent of elastinolysis. There was an -20% decrease in elastolytic activity in media containing 1-10% human serum as compared with cultures done in media depleted of proteinase inhibitors by acidification. Tables III and IV also show that the addition of plg to cultures of human macrophages in contact with purified elastin measurably increased elastin degradation. In nine separate experiments, plg increased elastin solubilization by an average of 30%. This increase was statistically significant, P < 0.005, using a paired t test (35) . The mechanism of the plasmin effect on human macrophage elastin degradation is unclear. As stated above, plasmin alone did not measurably increase elastin solubilization. In separate studies of stimulated murine peritoneal macrophages, we observed plasmin to enhance intact cell elastin degradation to a much greater extent, i.e., 2-to 10-fold (Chapman, H. A., and 0. L. Stone, manuscript submitted for publication). In this case the plasmin enhancement appears to be due to plasmin activation oflatent macrophage elastase activity.
Data in both
However, we have no direct evidence that human macrophages express or secrete a latent elastase.
Whether or not human macrophages express a latent elastase, live macrophage elastinolysis does not exclusively reflect the activity of a single enzyme. The addition of the lysosomal inhibitor chloroquine, 25-50 uM, to the medium over macrophages from each of the five subjects reported in Table III 5 gM, at concentrations that block phagocytosis, inhibited release 30-35% (data not shown). These findings indicate that a fraction, <40%, of the elastin solubilization by alveolar macrophages depends on intracellular proteolysis. Additional experiments with inhibitors of metallo-, thiol, or serine proteinases also indicated that elastin solubilization by live cells involves multiple proteinases. Using macrophages from five smoking subjects and culture condition described in Table III, but with Ca++-Mg"+-free DME, we observed EDTA, 0.1 mM, to inhibit elastin degradation by an average of 50% (range, 40-65%). Either the thiol proteinase inhibitor z-phenyl-alanyldiazomethylketone, I0-s M, or the neutrophil elastase inhibitor, succinyl-analyl-alanyl-prolyl-valyl-chloromethylketone, 0.1 mM, inhibited elastin solubilization in these five subjects 65-75% (36, 37) . These findings are consistent with a cooperative process (Table I) .
As the data in Fig. 1 indicate, there is a small but consistent release of 1251 (5-10% of total label) by intact alveolar macrophages after 4 h at 370C even in the absence of added p1g. This is confirmed in the 18-h fibrinolytic assay (Table II) where cells released -25% of the total label when cultured on '251I-fibrin in the absence of p1g. However, macrophages maintained on plg-free fibrin for 24-48 h did not progressively degrade the fibrin as judged visually and the 125I release did not increase linearly with time. We are therefore not convinced that the 125i-release in the absence ofplg entirely reflects proteolysis. Although macrophages may well degrade fibrin at low rates by plg-independent mechanisms, the released 1251 could also be due to iodase activity. Ragsdale and Arend (27) (21, 41) . These differences in physical properties are reflected in different biological properties. Tissue activator is bound and activated by fibrin, whereas urokinase is not (14) . Most characterizations of cell or tissue PA derive from studies of secreted PA, into culture media, but where compared the cell-associated and secreted forms have been similar (22, 42) . Our data indicate that human alveolar macrophages synthesize a single species of catalytically active PA, which is urokinase-like. The apparent molecular mass of active PA is indistinguishable from that of purified urokinase in nonreduced SDS gels (Fig. 2) and the enzyme activity is neutralized specifically by urokinase antibody (Fig. 3) . Independently, Bowen et al. (43) recently reached a similar conclusion. We further show here that alveolar macrophages actually synthesize urokinase-like PA as judged by immunoprecipitation of membrane fractions of metabolically labeled cells (Fig. 4) . The membrane location of PA activity has implications for the mechanisms of fibrinolysis by macrophages. First, the PA itself in a membrane location is likely to be relatively resistant to soluble protease inhibitors (13) . This may be important in that human as well as murine macrophages can release an inhibitor of urokinase-like PA, (44) . Second, the activation of plasmin is confined to the cell surface. Thus, although soluble urokinase does not bind to fibrin, its cell-associated location on macrophages allows for juxtaposition of the enzyme to fibrin via the cell. Although plasmin itself does not bind to macrophages, plasmin does tightly bind to fibrin and once bound has a threefold drop in its sensitivity to antiplasmins. The binding ofplasmin to fibrin rather than to antiplasmins is likely to occur if macrophages, bound to fibrin and expressing a membrane PA, activate plasmin near the cell-fibrin interface. This series of events explains the fibrinolysis mediated by human macrophages in contact with fibrin even in the presence of serum proteinase inhibitors (Table II) . Predictably, when macrophages were remote to the fibrin but cultured in the presence of proteinase inhibitors, much less fibrinolysis occurred. In this case, plasmin formed near the cell surface is largely neutralized by antiplasmins before binding fibrin.
It must be considered that this capability of macrophages to focus protein degradation at or near the cell surface even in the presence of soluble proteinase inhibitors may not be unique for fibrin. Plasmin has a wide spectrum of substrates including fibronectin, laminin, and other glycoproteins that are normal components of the extracellular matrix (45-47). Other neutral proteinases such as soluble elastase also bind tightly to their substrates (48) . If these proteinases are also bound to the cell surface, or released by macrophages near the substrate, proteolysis could eventuate even in the presence ofsoluble proteinase inhibitors. We observed this in fact to be the case with intact macrophage elastin degradation (Table IV) . In this experiment, appreciable elastinolysis only occurred when the macrophages contacted the elastin. When the cells contacted the substrate, however, elastinolysis occurred even in the presence of 10% human serum. Whether or not the elastase activity expressed by alveolar macrophages is released into the medium and/or is bound to the cell surface is unclear at this point. Campbell et al. (49) have reported a relative insensitivity of intact neutrophil proteolysis to proteinase inhibitors when these cells were in contact with fibronectin. Current concepts suggest that a balance between soluble proteinases and proteinase inhibitors is important to the homeostasis of lung architecture and that an imbalance in favor of proteinases mediates alveolar wall destruction that eventuates in emphysema (50) . The findings reported here of fibrinolysis and elastinolysis by intact human alveolar macrophages, if generalized, would suggest that the proper topology among cells, substrates, and inhibitors could result in matrix degradation regardless of the balance between proteinases and inhibitors in the soluble phase. Still, a deficiency of soluble proteinase inhibitors would likely accelerate the degradative process. The rates of fibrin or elastin degradation by intact macrophages were higher in media depleted ofproteinase inhibitors.
Werb et al. (47, 52) and Jones et al. (51) have reported a series of experiments examining the degradative mechanisms of live murine macrophages cultured on extracellular matrices deposited in vitro by smooth muscle cells. They metabolically labeled whole matrices with [3H]proline and monitored degradation ofindividual components, i.e., glycoproteins, collagen, or elastin, by macrophages, as the difference in label released by macrophages and that released by specific enzymes, i.e., trypsin, collagenase, or elastase. They observed that pretreatment of intact matrices with trypsin or plasmin or incubation of cells on matrices with added pig accelerated the breakdown ofelastin components by the macrophages. They further observed that much ofthe matrix degradation occurred in pericellular locations and that elastase activity of live cells as compared with soluble elastase was relatively resistant to inhibition by a-2-macroglobulin. Our data support these findings. We developed an assay of intact macrophage elastinolysis of purified insoluble elastin (Chapman, H. A., and 0. L. Stone, manuscript submitted for publication). We observed that when the elastin was mixed with fibrin, the addition of plg was critical to the elastin degradation by alveolar lavage cells (Table III) although plasmin only weakly accelerated elastin degradation by macrophages on pure elastin and had no effect on elastin in the absence of cells. Similarly, contact of the macrophages with the elastin was critical to elastinolysis (Table IV) , but intact cells in contact with elastin could measurably degrade elastin even in the presence of serum proteinase inhibitors. Together, these data suggest that plasmin, and therefore macrophage PA, have integral roles in matrix metabolism by alveolar macrophages. This extends beyond the purpose of simply resolving tissue fibrin to include the degradation of tissue proteins toward which plasmin has no direct proteolytic effect. Indeed in some cases, as shown in Table IV , PA and plg, not elastase, may be rate limiting in elastin degradation. This may be important to the movement of lung macrophages within normal interstitial tissues of the lung and may be relevant to the destruction oflung tissue common to a number of inflammatory processes in which alveolar macrophages are prominent.
